Results 191 to 200 of about 3,231,328 (345)

Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks Trial [PDF]

Usha Chakravarthy, Roy Schwartz, Robyn H. Guymer, Frank G. Holz, Aleksandra Rachitskaya, Stela Vujosevic, Philip Lewis, Hanne Vorwerk, A. Yasin Alibhai, Eric M. Moult, Marco U Morales, Caleb Bliss, Caroline R. Baumal, Nadia K. Waheed   +13 more
openalex   +1 more source

Genetics in Ophthalmology

Journal of Ophthalmology, 2018
Lev Prasov, Stephen T. Armenti, Virginia Miraldi Utz, Julia E. Richards, Robert B. Hufnagel   +4 more
doaj   +1 more source

Deep Learning–Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Peripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning–based multiclass classification ...
Chaima Ben Rabah, Ioannis N. Petropoulos, Mark Stettner, Maryam Ferdousi, Uazman Alam, Nathan Efron, Ahmed Serag, Rayaz A. Malik   +7 more
wiley   +1 more source

Visual Function in Athletes from Different Team Sports and Non-Athlete Controls. [PDF]

Life (Basel)
Nascimento H, Roque A, Martinez-Perez C.
europepmc   +1 more source

Rapid and Objective Assessment of Neural Function in Autism Spectrum Disorder Using Transient Visual Evoked Potentials

, 2016
Paige M. Siper, Vance Zemon, James Gordon, Julia George-Jones, Stacey Lurie, Jessica Zweifach, Teresa Tavassoli, A. Ting Wang, Jesslyn Jamison, Joseph D. Buxbaum, Alexander Kolevzon   +10 more
openalex   +2 more sources

Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein, Haoqi Sun, Sophie Lehnerer, Lea Gerischer, Maximilian Mönch, Christian Meisel, Andreas Meisel, Pushpa Narayanaswami   +7 more
wiley   +1 more source

AAV-delivered engineered suppressor tRNA rescues visual function in mice with an inherited retinal disease. [PDF]

Nat Commun
Ren C, Song L, Hu M, Jin X, Liang L, Liu F, Su J, Fu J, Yang Y, Liu M, Xu Q, Wu X, Luo M, Ye Q, Li Q, An Y, Li M, She K, Wei Y, Lu F, Yang Y.   +20 more
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

In vivo mitochondrial base editing restores genotype and visual function in a mouse model of LHON. [PDF]

Nat Commun
Kim S, Kim J, Cha S, Ju S, Lim CJ, Hong S, Bae J, Oh Y, Jung S, Kim SP, Shin HS, Yoon JH, Park J, Ryou S, Lim SY, Lee SB, Choi SH, Park SJ, Choi CG, Choi M, Kim LK, Park J, Lee S, Seo KY, Seong JK, Kim K, Kim JS, Lee H.   +27 more
europepmc   +1 more source

Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz, Josefine Eck, Joel S. Winston, Kate Baker   +3 more
wiley   +1 more source